NCT03510923 (FANCY) is a clinical trial of Inspection and palpation of the appendix in Appendix, sponsored by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA).

Who is sponsoring NCT03510923?

NCT03510923 is sponsored by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA).

What drugs are being tested in NCT03510923?

Interventions in NCT03510923: Inspection and palpation of the appendix, Inspection and palpation of the gallbladder.

What condition does NCT03510923 study?

NCT03510923 studies Appendix, Appendectomy, Appendiceal Neoplasms, Gallbladder, Cholecystectomy, Gallbladder Neoplasms.

Is NCT03510923 still recruiting?

NCT03510923 is currently completed. Last updated 4 June 2024.

Last reviewed 2024-06-04 · How we verify

NCT03510923: FANCY

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Selective Rather Than Routine Histopathological Examination Following Appendectomy and Cholecystectomy

Completed Last updated 4 June 2024

What this trial tests

trial testing Inspection and palpation of the appendix in Appendix in 17,380 participants. Completed in 24 December 2020.

Timeline

1 May 2018

Primary endpoint
1 February 2020

24 December 2020

Quick facts

Lead sponsor	Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Status	Completed
Study type	OBSERVATIONAL
Enrollment	17,380
Start date	1 May 2018
Primary completion	1 February 2020
Estimated completion	24 December 2020
Sites	1 location across Netherlands

Drugs / interventions tested

Inspection and palpation of the appendix
Inspection and palpation of the gallbladder

Conditions studied

Appendix — all drugs for Appendix →
Appendectomy — all drugs for Appendectomy →
Appendiceal Neoplasms — all drugs for Appendiceal Neoplasms →
Gallbladder — all drugs for Gallbladder →

Sponsor

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) — full company profile →

Who can join

Eligibility, any sex, with Appendix or Appendectomy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The FANCY study will investigate whether a selective policy of histopathological examination of appendices and gallbladders based on the intraoperative findings of the surgeon is safe and cost-effective.

Publications & conference data

5 peer-reviewed publications reference this trial (live from Europe PMC):

Safe, selective histopathological examination of gallbladder specimens: a systematic review.
Bastiaenen VP, Tuijp JE, van Dieren S, Besselink MG, et al · · 2020 · cited 14× · PMID 32639049 · DOI 10.1002/bjs.11759
Safety and economic analysis of selective histopathology following cholecystectomy: multicentre, prospective, cross-sectional FANCY study.
Bastiaenen VP, van Vliet JLP, de Savornin Lohman EAJ, Corten BJGA, et al · · 2022 · cited 6× · PMID 35245363 · DOI 10.1093/bjs/znab469
Oncological Safety and Potential Cost Savings of Routine vs Selective Histopathological Examination After Appendectomy: Results of the Multicenter, Prospective, Cross-Sectional FANCY Study.
Bastiaenen VP, de Jonge J, Corten BJGA, de Savornin Lohman EAJ, et al · · 2023 · cited 5× · PMID 35072428 · DOI 10.1097/sla.0000000000005228
Safety and cost analysis of selective histopathological examination following appendicectomy and cholecystectomy (FANCY study): protocol and statistical analysis plan of a prospective observational multicentre study.
Bastiaenen VP, Corten BJ, de Savornin Lohman EA, de Jonge J, et al · · 2019 · cited 5× · PMID 31874901 · DOI 10.1136/bmjopen-2019-035912
Abstracts presented at the 14th European Colorectal Congress (#ECCStGallen), 29.11.2020-2.12.2020, St.Gallen, Switzerland.
Adamina M, Pozza G, #ECCStGallen Scientific Committee. · · 2021 · cited 2× · PMID 33616759 · DOI 10.1007/s10151-021-02408-9

Verify or expand the search:

Other Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) trials

Trials by the same sponsor.

NCT07301021 — Velopharyngeal Insufficiency After Maxillomandibular Advancement Osteotomy in Obstructive Sleep Apnea Patients · not yet recruiting
NCT07359482 — sElective Serotonin reuPtake inhibitoRs In posT-covid After COVID-19 · Phase 3 · not yet recruiting
NCT07457957 — Effectiveness of an mHealth Innovation on the Impact of Menstrual Complaints in Adolescents · NA · not yet recruiting
NCT06909045 — Adaptive vs. Continuous Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease · NA · recruiting
NCT07316127 — Immunoadsorption in Autoimmune Long COVID · Phase 2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03510923 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Last refreshed: 4 June 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03510923.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing